动静脉瘘/人工血管建立术围术期阿片类与非阿片类处方模式
本研究回顾2016年9月至2018年1月164例血液透析通路建立患者的病历,比较住院与门诊患者术后阿片类处方模式。住院患者术后即刻接受阿片类药物的比例及出院时处方平均剂量均显著高于门诊患者,且人工血管患者比动静脉瘘患者更常被处方阿片类药物,而替代镇痛药物使用率低。
要点
- 住院患者术后即刻使用阿片类药物比例显著高于门诊患者(AVF 72% vs 19%;AVG 62% vs 25%)。
- AVG患者出院时阿片类处方率高于AVF患者(37% vs 8%),且住院患者平均处方剂量更高。
- 术后替代镇痛药物使用率低(AVF:对乙酰氨基酚18%、NSAID 1%;AVG:对乙酰氨基酚24%、NSAID 0%)。
核心结论
- 住院患者术后即刻接受阿片类药物的比例和平均剂量均高于门诊患者,AVG患者比AVF患者更常被处方阿片类药物,替代镇痛药物使用率低提示存在优化镇痛和减少阿片类处方的机会。
研究设计与样本
- 回顾性队列研究,纳入2016年9月至2018年1月接受AVF或AVG建立的164例非慢性阿片类治疗患者,比较住院与门诊、AVF与AVG及不同麻醉方式间的阿片类处方模式,统计分析采用卡方检验和t检验。
主要发现
- 住院患者术后即刻接受阿片类比例显著高于门诊患者(AVF:72% vs 19%,P<0.001;AVG:62% vs 25%,P=0.001)。
- AVG患者出院时阿片类处方率高于AVF患者(37% vs 8%,P<0.001),门诊管理的AVG患者中48%出院时带阿片类处方。
- 住院患者平均术后阿片类总剂量显著高于门诊患者(AVF:28.73 MMEs vs 1.27 MMEs,P<0.001;AVG:22.11 MMEs vs 2.16 MMEs,P=0.005)。
- 全身麻醉患者术后接受阿片类比例高于局部麻醉加镇静患者(AVF:54% vs 24%,P=0.027;AVG:61% vs 17%,P<0.001)。
- 恢复室和住院单元报告术后疼痛的患者比例在门诊与住院间无显著差异(AVF:21% vs 28%,P=0.534;AVG:23% vs 44%,P=0.061)。
临床怎么用
- 透析通路建立围术期应关注住院患者和AVG患者的阿片类处方,考虑增加非阿片类镇痛药的使用以优化疼痛管理并减少阿片类暴露。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To evaluate postoperative opioid prescribing patterns in patients undergoing hemodialysis access creation. METHODS: Operative logs were reviewed to identify patients undergoing creation of arteriovenous fistula (AVF) or graft (AVG) from September 2016 to January 2018. Immediate postoperative opioid prescriptions were compared for ambulatory patients versus inpatients. Opioid prescriptions at the time of discharge for inpatients were recorded. Rates of opioid prescribing were standardized by conversion to morphine milligram equivalents (MMEs). Opioid use postoperatively and at the time of discharge based on anesthetic technique, general anesthesia versus regional or local anesthesia with sedation were compared. Alternative pain medications administered and pain scores were recorded. Comparisons were made between the percentage of opioid use and doses administered between AVF and AVG patient groups, ambulatory and inpatients, and type of anesthetic technique used. Statistical analysis was performed with chi-square and t-tests. RESULTS: We identified 164 patients undergoing AV access creation but not receiving chronic opioid therapy. A significantly higher percentage of inpatients received opioids in the immediate postoperative period than ambulatory patients (AVF: 72% vs. 19%, P < 0.001; AVG: 62% vs. 25%, P = 0.001). Overall, all AVG patients were more likely to be discharged with an opioid prescription than all AVF patients (37% vs. 8%, P < 0.001). Of AVG patients managed in the ambulatory setting, 48% were discharged with an opioid prescription. The mean total opioid postoperative dose prescribed to inpatients was significantly higher than that prescribed to ambulatory patients for both fistulas (28.73 MMEs vs. 1.27 MMEs, P < 0.001) and grafts (22.11 MMEs vs. 2.16 MMEs, P = 0.005). General anesthesia patient groups were more likely to receive opioids postoperatively than local anesthesia with sedation patients for both AVF (54% vs. 24%, P = 0.027) and AVG creation (61% vs. 17% P < 0.001). Postoperative alternative medication use in the hospital was low with 18% acetaminophen and 1% nonsteroidal anti-inflammatory drug use for AVF patient groups and 24% acetaminophen and 0% nonsteroidal anti-inflammatory drug use for AVG patient groups. The percentage of patients reporting postoperative pain in the recovery room and on the inpatient units was comparable between ambulatory and inpatient settings (AVF: 21% vs. 28%, P = 0.534; AVG: 23% vs. 44%, P = 0.061). CONCLUSIONS: A higher percentage of inpatients undergoing hemodialysis access received opioids when compared with ambulatory patients in the immediate postoperative period. Inpatients were prescribed higher mean doses than ambulatory patients. AVG patient groups were prescribed more opioids than AVF patient groups. Alternative analgesic agent use was low, suggesting an opportunity for improved pain control and opioid reduction. Dialysis access creation represents an opportunity to improve on opioid prescribing patterns.
引用
- Phair J, Choinski K, Carnevale M, et al. Perioperative Opioid and Nonopioid Prescribing Patterns in AVF/AVG Creation. Ann Vasc Surg. 2020. PMID: 32949735. doi:10.1016/j.avsg.2020.09.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。